Search results
Merck's KEYTRUDA shows survival benefit in gastric cancer trial By Investing.com
Investing.com· 13 hours agoMerck & Co., Inc., a leading pharmaceutical company, announced positive results from the Phase 3...
Is Merck Stock Fully Valued At $130?
Forbes· 1 day agoMerck (NYSE: MRK) recently reported its Q1 results, with revenues and earnings exceeding our estimates. The growth was primarily driven by higher sales...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 7 days agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Merck shares target raised on strong Q1 performance By Investing.com
Investing.com· 6 days agoOn Thursday, Truist Securities adjusted the stock price target for Merck (NYSE:MRK), a global...
Merck KGaA's Dividend Analysis
GuruFocus.com via Yahoo Finance· 3 days agoMerck KGaA (MKKGY) recently announced a dividend of $0.47 per share, payable on 2024-05-09, with the ex-dividend date set for 2024-04-29. As investors...
Merck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoMerck & Co., Inc. (NYSE:MRK) Q1 2024 Earnings Call Transcript April 25, 2024 Merck & Co., Inc. beats...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
KFGO· 7 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
Merck reports promising V116 vaccine trial results By Investing.com
Investing.com· 3 days agoMerck & Co. (NYSE: MRK) has presented new data from its Phase 3 STRIDE-10 trial of V116, an...
Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $143.00
ETF DAILY NEWS· 3 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) had its target price boosted by Truist Financial from $142.00 to $143.00 in a research report released on Friday, Benzinga reports ...
Dow Jones Darling Merck Pops As Cancer 'Star' Drives Quarterly Beat
Investor's Business Daily· 7 days agoMerck's bread-and-butter cancer drug grew by double digits again in the first quarter.